Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts.
N'takpe JB, Gabillard D, Moh R, Gardiennet E, Emieme A, Badje A, Kouame GM, Toni TD, Karcher S, Carrou JL, Ménan H, Danel C, Eholie SP, Rouzioux C, Anglaret X. N'takpe JB, et al. Among authors: rouzioux c. EBioMedicine. 2020 Jun;56:102815. doi: 10.1016/j.ebiom.2020.102815. Epub 2020 Jun 5. EBioMedicine. 2020. PMID: 32512517 Free PMC article. Clinical Trial.
Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.
Messou E, Chaix ML, Gabillard D, Yapo V, Toni TD, Minga A, Kouakou MG, Ouattara E, Rouzioux C, Danel C, Eholie SP, Anglaret X. Messou E, et al. Among authors: rouzioux c. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):211-9. doi: 10.1097/QAI.0b013e3182a009e4. J Acquir Immune Defic Syndr. 2013. PMID: 23797690 Free PMC article.
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni TD, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X; Temprano ANRS 12136 Study Group. Badje A, et al. Among authors: rouzioux c. Lancet Glob Health. 2017 Nov;5(11):e1080-e1089. doi: 10.1016/S2214-109X(17)30372-8. Lancet Glob Health. 2017. PMID: 29025631 Free article. Clinical Trial.
Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1-Infected West African Adults With High CD4 Counts.
Affi R, Gabillard D, Dunyach-Remy C, Ntakpe JB, Moh R, Badje A, Kouame GM, Karcher S, Le Carrou J, Danel C, Chevalier MF, Rouzioux C, Eholie SP, Lavigne JP, Inwoley A, Anglaret X, Weiss L. Affi R, et al. Among authors: rouzioux c. J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):138-145. doi: 10.1097/QAI.0000000000002533. J Acquir Immune Defic Syndr. 2021. PMID: 33074857
Elite and viremic HIV-1 controllers in West Africa.
N'takpé JB, Gabillard D, Moh R, Gardiennet E, Toni TD, Kouame GM, Badje A, Emieme A, Karcher S, Le Carrou J, Ménan H, Danel C, Eholie SP, Rouzioux C, Anglaret X, Lambotte O. N'takpé JB, et al. Among authors: rouzioux c. AIDS. 2022 Jan 1;36(1):29-38. doi: 10.1097/QAD.0000000000003072. AIDS. 2022. PMID: 34524145 Free PMC article. Clinical Trial.
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation.
Gabillard D, N'Takpé JB, Chaix ML, Kouame GM, Moh R, Toni TD, Le Carrou J, Karcher S, Badje A, Emieme A, Menan H, Danel C, Anglaret X, Eholié SP; Temprano ANRS 12136 study group. Gabillard D, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2666-2674. doi: 10.1093/jac/dkab225. J Antimicrob Chemother. 2021. PMID: 34533197 Clinical Trial.
Two-months-off, four-months-on antiretroviral regimen increases the risk of resistance, compared with continuous therapy: a randomized trial involving West African adults.
Danel C, Moh R, Chaix ML, Gabillard D, Gnokoro J, Diby CJ, Toni T, Dohoun L, Rouzioux C, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 Trial Group. Danel C, et al. Among authors: rouzioux c. J Infect Dis. 2009 Jan 1;199(1):66-76. doi: 10.1086/595298. J Infect Dis. 2009. PMID: 18986246 Clinical Trial.
Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, Kouakou M, Danel C, Sloan C, Rouzioux C, Freedberg KA, Anglaret X. Messou E, et al. Among authors: rouzioux c. J Acquir Immune Defic Syndr. 2011 Apr;56(4):356-64. doi: 10.1097/QAI.0b013e3182084b5a. J Acquir Immune Defic Syndr. 2011. PMID: 21191309 Free PMC article.
511 results